Baxter International (BAX) Total Current Liabilities (2009 - 2026)
Baxter International (BAX) posted quarterly Total Current Liabilities of $3.6 billion for Q2 2026, up 22.18% year-over-year from $2.9 billion in Q2 2025, and down 2.76% quarter-over-quarter from $3.7 billion in Q1 2026.
Baxter International (BAX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Total Current Liabilities for 18 consecutive years, with $3.6 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 22.18% year-over-year to $3.6 billion; the TTM figure through Jun 2026 stood at $3.6 billion (up 22.18% YoY), while the FY2025 annual figure was $3.0 billion, down 54.38% from the prior year.
- Total Current Liabilities retreated to $3.6 billion in Q2 2026 per BAX's latest filing, from $3.7 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $6.5 billion in Q4 2024 and bottomed at $2.9 billion in Q2 2025.
- Historically, Total Current Liabilities has averaged $4.7 billion across 5 years, with a median of $4.3 billion in 2022.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 67.45% — and 2025, when it plunged 54.38%.
- Baxter International's Total Current Liabilities stood at $4.7 billion in 2022, then soared by 37.05% to $6.5 billion in 2023, then increased by 0.12% to $6.5 billion in 2024, then slumped by 54.38% to $3.0 billion in 2025, then advanced by 20.91% to $3.6 billion in 2026.
- Business Quant data shows BAX's Total Current Liabilities at $3.6 billion in Q2 2026, $3.7 billion in Q1 2026, and $3.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.51 Bn | 127.30 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.76 Bn | 50.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.39 Bn | 34.04 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.45 Bn | 31.98 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 28.29 Bn | 25.61 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 24.92 Bn | 24.49 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.28 Bn | 14.88 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.77 Bn | 14.63 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.51 Bn | 11.36 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Align Technology | 11.35 Bn | 10.25 Bn | 757.43 Mn | 1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.59 Bn |
| Mar 31, 2026 | 3.69 Bn |
| Dec 31, 2025 | 2.97 Bn |
| Sep 30, 2025 | 3.78 Bn |
| Jun 30, 2025 | 2.94 Bn |
| Mar 31, 2025 | 3.48 Bn |
| Dec 31, 2024 | 6.51 Bn |
| Sep 30, 2024 | 6.20 Bn |
| Jun 30, 2024 | 6.13 Bn |
| Mar 31, 2024 | 6.37 Bn |
| Dec 31, 2023 | 6.50 Bn |
| Sep 30, 2023 | 6.21 Bn |
| Jun 30, 2023 | 5.77 Bn |
| Mar 31, 2023 | 4.76 Bn |
| Dec 31, 2022 | 4.75 Bn |
| Sep 30, 2022 | 3.71 Bn |
| Jun 30, 2022 | 3.92 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 4.24 Bn |
| Sep 30, 2021 | 3.44 Bn |